Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
55m
Hold Rating Maintained Amidst Revance Therapeutics Acquisition Uncertainty
Mizuho Securities analyst Uy Ear has maintained their neutral stance on RVNC stock, giving a Hold rating on January 17.Invest with Confidence: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Crash at Reagan airport
Los Angeles wildfire updates
Cause of death revealed
Asteroid may hit Earth
Signs education orders
Ex-worker admits to theft
Michigan priest loses license
Blames DEI for crash
Hamas confirms death
FDA approves painkiller
Day 2 of Senate hearing
First spacewalk together
Wildfire erupts in NC
Senate confirmation hearing
US economy grew 2.3%
Shiffrin finishes 10th
Hamas frees more hostages
Searching for joyriders
Deputy shooting sentence
Weekly jobless claims fall
S3 release date revealed
Syria’s transitional pres
Ebola outbreak in Uganda
DOJ weighs dropping case?
'As Tears Go By' singer dies
Accused of sexual misconduct
2 more victims in indictment
DOJ sues to block deal
Partners w/ US national labs
Nashville bids for franchise
Ground stop amid IT outage
Feedback